To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCNT1_TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
306 supporting clones for gene CCNT1_ back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001240.2   .a 1 to 2568 1 to 2568 exact RefSeq,   2568/2568
(100 %)
1 diff
(100.0 %id)
AK290990   .a 101 to 2504 1 to 2404 R251G tiling clone,   2404/2404
(100 %)
3 diff
(99.9 %id)
DA712472   .a 102 to 666 2 to 569   capped   568/568
(100 %)
5 diff
(99.2 %id)
DB040273 testis .a 228 to 803 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BP277573 Kidney .a 234 to 814 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP364073 lung .a 269 to 850 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AF048730   .a 280 to 2601 1 to 2320 Q77R tiling clone,   2320/2360
(98 %)
16 diff
(99.4 %id)
DW437884 Liver .a 286 to 522 11 to 247       237/247
(95 %)
7 diff
(97.2 %id)
BP248714 Kidney .a 293 to 879 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DA843206 placenta .a 296 to 855 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
AF045161   .a 324 to 2504 1 to 2181 exact     2181/2181
(100 %)
1 diff
(100.0 %id)
EC482263 Prostate .a 1069 to 1159 1 to 91       91/91
(100 %)
0 diff
(100 %id)
T90767 liver and spleen .a 1300 to 1756 477 to 8       470/482
(97 %)
0 diff
(100 %id)
BQ352690 head_neck .a 1516 to 1877 370 to 4       367/370
(99 %)
0 diff
(100 %id)
FN052546 breast carcinoma .a 1841 to 1911 1 to 71       71/71
(100 %)
0 diff
(100 %id)
BM713665 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1923 to 2523 1 to 601     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 601/605
(99 %)
4 diff
(99.4 %id)
AW895737 nervous_normal .a 1925 to 2377 14 to 466       453/466
(97 %)
6 diff
(98.8 %id)
AU184981 skin .a 2036 to 2501 1 to 466       466/466
(100 %)
1 diff
(99.8 %id)
AA676452 liver and spleen .a 2121 to 2382 264 to 3       262/264
(99 %)
0 diff
(100 %id)
AW392808 stomach .a 2172 to 2360 1 to 192       192/192
(100 %)
10 diff
(94.8 %id)
BQ024675 placenta .a 2196 to 2518 325 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 323/325
(99 %)
0 diff
(100 %id)
FN162680 breast carcinoma .a 2268 to 2334 1 to 69       69/69
(100 %)
5 diff
(92.8 %id)
AW161863 brain, frontal lobe .a 2272 to 2713 1 to 441   tiling clone,   441/441
(100 %)
1 diff
(99.8 %id)
BQ023874 placenta .a 2324 to 2518 197 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 195/197
(98 %)
0 diff
(100 %id)
BM787321 stomach .b 1 to 542 1 to 544   tiling clone,   544/544
(100 %)
4 diff
(99.3 %id)
AK094528 alzheimer cortex .b 6 to 2724 1 to 2717 P628T tiling clone, available from FLJ,   2717/2717
(100 %)
11 diff
(99.6 %id)
DA134986 alzheimer cortex .b 7 to 566 2 to 561   capped   560/560
(100 %)
6 diff
(99.0 %id)
DB301132 alzheimer cortex .b 2192 to 2724 532 to 1   tiling clone,   532/532
(100 %)
2 diff
(99.7 %id)
CD687287 normal nasopharynx .c -8 to 653 25 to 685   tiling clone,   661/685
(96 %)
6 diff
(99.2 %id)
CD358219 testis .c 1 to 550 136 to 692       563/1204
(46 %)
32 diff
(97.4 %id)
BI464132 testis .c 1 to 740 7 to 754       753/951
(79 %)
28 diff
(97.1 %id)
CD685219 normal nasopharynx .c 1 to 483 36 to 518       485/518
(93 %)
6 diff
(98.9 %id)
DB448612 testis .c 1 to 397 3 to 401       401/402
(99 %)
17 diff
(95.8 %id)
DA023551   .c 1 to 564 3 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA097952 cerebellum .c 1 to 564 3 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA101395 cerebellum .c 1 to 563 3 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA114810 cerebellum .c 1 to 562 3 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
DA239761 brain .c 1 to 574 3 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA480828   .c 1 to 558 3 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA488887 brain .c 1 to 562 3 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA526266 brain .c 1 to 559 3 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
DB103918 thymus .c 1 to 559 3 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DB240594 trachea .c 1 to 586 3 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DB248125 uterus .c 1 to 514 3 to 516   capped   515/515
(100 %)
3 diff
(99.5 %id)
DB450317 testis .c 1 to 465 1 to 464       464/464
(100 %)
4 diff
(99.2 %id)
DB288754 uterus .c 1 to 539 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
CF593897 Human Placenta, placenta .c 2 to 734 29 to 763       735/768
(95 %)
11 diff
(98.6 %id)
AV759174 bone marrow .c 2 to 652 1 to 642       647/677
(95 %)
36 diff
(94.7 %id)
DA164184 amygdala .c 3 to 570 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA234274 brain .c 3 to 588 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA243044 brain .c 3 to 589 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA275493 corpus callosum .c 3 to 560 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA304439 hippocampus .c 3 to 587 2 to 586   capped   585/585
(100 %)
5 diff
(99.2 %id)
DA549092   .c 3 to 562 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BU933543 mixed (pool of 40 RNAs) .c 3 to 805 1 to 807       807/807
(100 %)
12 diff
(98.6 %id)
DA629766 Kidney .c 3 to 570 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA752292   .c 3 to 579 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DB259368 uterus .c 3 to 591 2 to 590   capped   589/589
(100 %)
6 diff
(99.0 %id)
DB499873 hypothalamus .c 5 to 515 1 to 511       511/511
(100 %)
4 diff
(99.3 %id)
BM194597 leukopheresis .c 5 to 219 1 to 215       215/217
(99 %)
17 diff
(92.2 %id)
DB487496 hypothalamus .c 6 to 453 1 to 447       447/447
(100 %)
6 diff
(98.7 %id)
DB503309 hypothalamus .c 6 to 488 1 to 483       483/489
(98 %)
5 diff
(99.0 %id)
BI599436 brain, hypothalamus .c 7 to 762 8 to 764       757/764
(99 %)
12 diff
(98.5 %id)
TI_45211566   .c 7 to 762 88 to 844       757/844
(89 %)
11 diff
(98.7 %id)
CN427344 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 9 to 764 11 to 770       760/770
(98 %)
11 diff
(98.6 %id)
CD517313 White Matter .c 9 to 729 1 to 727       727/911
(79 %)
13 diff
(98.6 %id)
AL556371 placenta .c 12 to 904 1 to 889       889/889
(100 %)
7 diff
(99.3 %id)
BG253607 adenocarcinoma, cell line, Liver .c 14 to 773 1 to 765       765/952
(80 %)
17 diff
(98.3 %id)
BG420261 Kidney, renal cell adenocarcinoma .c 15 to 665 1 to 652       654/981
(66 %)
10 diff
(99.0 %id)
BQ944005 large cell carcinoma, lung .c 15 to 604 1 to 594       594/991
(59 %)
28 diff
(97.2 %id)
BG336104 choriocarcinoma, placenta .c 16 to 723 1 to 700       702/923
(76 %)
13 diff
(98.6 %id)
BG480479 choriocarcinoma, placenta .c 16 to 858 1 to 844       844/910
(92 %)
31 diff
(96.6 %id)
BG481157 choriocarcinoma, placenta .c 16 to 685 1 to 672       672/673
(99 %)
6 diff
(99.2 %id)
BQ897231 dorsal root ganglia .c 16 to 881 1 to 870       870/871
(99 %)
6 diff
(99.4 %id)
TI_57161985   .c 16 to 790 36 to 805       772/806
(95 %)
17 diff
(97.9 %id)
BC009746 Placenta, choriocarcinoma .c 17 to 2165 1 to 2149 P445T tiling clone, available from MGC, AAA   2149/2149
(100 %)
1 diff
(100.0 %id)
BM471606 leiomyosarcoma, uterus .c 17 to 604 84 to 673       590/1412
(41 %)
19 diff
(98.7 %id)
BG722684 testis .c 18 to 762 1 to 747       749/747
(100 %)
15 diff
(98.0 %id)
BI226323 Burkitt lymphoma, lymph .c 20 to 842 1 to 824       822/848
(96 %)
23 diff
(97.3 %id)
BI832632 pooled pancreas and spleen .c 20 to 790 1 to 766       768/767
(100 %)
10 diff
(98.7 %id)
BU934801 mixed (pool of 40 RNAs) .c 21 to 773 1 to 756       756/798
(94 %)
13 diff
(98.4 %id)
DA301720 hippocampus .c 25 to 563 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA383225 thalamus .c 27 to 572 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA160999 amygdala .c 28 to 604 2 to 580   capped   579/579
(100 %)
4 diff
(99.4 %id)
BG326956 Kidney, renal cell adenocarcinoma .c 28 to 512 1 to 485       485/485
(100 %)
3 diff
(99.4 %id)
BG533828 Liver .c 28 to 716 1 to 693       693/693
(100 %)
18 diff
(97.5 %id)
DA749095   .c 28 to 594 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA887665   .c 28 to 574 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
CV573436 cornea, eye .c 29 to 648 1 to 620       620/620
(100 %)
0 diff
(100 %id)
BE781711 eye, retinoblastoma .c 30 to 755 1 to 724       726/900
(80 %)
23 diff
(97.5 %id)
BU528721 epidermoid carcinoma, cell line, lung .c 30 to 919 1 to 891       891/892
(99 %)
4 diff
(99.6 %id)
DN914352   .c 33 to 727 1 to 689       689/689
(100 %)
12 diff
(98.3 %id)
BI839123 pooled pancreas and spleen .c 33 to 771 31 to 775       745/952
(78 %)
19 diff
(98.1 %id)
BM471537 eye, retinoblastoma .c 33 to 1036 1 to 1008       1008/1034
(97 %)
23 diff
(97.8 %id)
BM546474 brain, hippocampus .c 33 to 1036 21 to 1028       1008/1086
(92 %)
22 diff
(98.0 %id)
TI_57168326   .c 33 to 771 31 to 775       745/952
(78 %)
19 diff
(98.1 %id)
BE735633 adenocarcinoma, Pancreas .c 34 to 765 1 to 736       738/896
(82 %)
35 diff
(96.1 %id)
BF204226 muscle, rhabdomyosarcoma .c 34 to 775 1 to 730       732/879
(83 %)
24 diff
(97.3 %id)
BF305917 muscle, rhabdomyosarcoma .c 34 to 755 1 to 711       713/920
(77 %)
18 diff
(98.1 %id)
BF308867 muscle, rhabdomyosarcoma .c 34 to 751 1 to 709       711/817
(87 %)
20 diff
(97.6 %id)
BG827450 muscle, rhabdomyosarcoma .c 34 to 688 1 to 655       655/656
(99 %)
11 diff
(98.4 %id)
BE732454 choriocarcinoma, placenta .c 35 to 874 1 to 820       822/916
(89 %)
34 diff
(96.3 %id)
BE279528 choriocarcinoma, placenta .c 36 to 612 1 to 578       578/722
(80 %)
7 diff
(99.1 %id)
BE409185 choriocarcinoma, placenta .c 36 to 694 1 to 657       659/711
(92 %)
6 diff
(99.2 %id)
BE733795 choriocarcinoma, placenta .c 36 to 773 1 to 741       743/754
(98 %)
13 diff
(98.3 %id)
BE731481 choriocarcinoma, placenta .c 36 to 777 1 to 740       742/859
(86 %)
16 diff
(98.2 %id)
BE296714 muscle, rhabdomyosarcoma .c 40 to 671 1 to 631       631/632
(99 %)
2 diff
(99.7 %id)
BE269574 Burkitt lymphoma, lymph .c 40 to 659 1 to 617       619/637
(97 %)
7 diff
(99.0 %id)
BE270052 Burkitt lymphoma, lymph .c 40 to 675 1 to 631       633/635
(99 %)
8 diff
(98.8 %id)
BX493177   .c 42 to 362 1 to 321       321/321
(100 %)
4 diff
(98.8 %id)
BG828966 muscle, rhabdomyosarcoma .c 42 to 654 1 to 626       565/626
(90 %)
20 diff
(96.9 %id)
BE903933 epithelioid carcinoma, Pancreas .c 45 to 604 9 to 587       581/609
(95 %)
28 diff
(95.5 %id)
BM806589 leiomyosarcoma, uterus .c 47 to 978 1 to 930       930/1070
(86 %)
10 diff
(99.1 %id)
DA278834 corpus callosum .c 51 to 524 69 to 542   capped   541/541
(100 %)
3 diff
(99.5 %id)
BE795764 lung, small cell carcinoma .c 51 to 851 1 to 799       799/799
(100 %)
12 diff
(98.5 %id)
NM_017822.3   .c 51 to 2368 67 to 2384 exact RefSeq, AAA   2384/2384
(100 %)
0 diff
(100 %id)
CD628650   .c 56 to 150 95 to 1       95/101
(94 %)
1 diff
(99.1 %id)
CD628651   .c 56 to 150 7 to 101       95/102
(93 %)
2 diff
(98.1 %id)
BI225776 Burkitt lymphoma, lymph .c 62 to 720 32 to 738       647/743
(87 %)
88 diff
(88.2 %id)
BC013900 Ovary, adenocarcinoma .c 65 to 2157 1 to 2093   available from MGC, AAA   2093/2093
(100 %)
2 diff
(100.0 %id)
BE743924 adenocarcinoma cell line, ovary .c 84 to 542 1 to 482       415/482
(86 %)
6 diff
(98.8 %id)
BE746790 adenocarcinoma cell line, ovary .c 84 to 851 1 to 763       763/928
(82 %)
15 diff
(98.4 %id)
BE746634 adenocarcinoma cell line, ovary .c 86 to 898 1 to 819       816/820
(99 %)
25 diff
(97.0 %id)
R57685   .c 98 to 245 16 to 160       145/160
(90 %)
6 diff
(96.3 %id)
BU181060 large cell carcinoma, lung .c 190 to 870 1 to 687       687/849
(80 %)
15 diff
(98.3 %id)
FN130434 breast carcinoma .c 191 to 293 1 to 103       103/103
(100 %)
0 diff
(100 %id)
BG826854 muscle, rhabdomyosarcoma .c 217 to 1036 1 to 824       824/874
(94 %)
15 diff
(98.3 %id)
BQ224284 embryonal carcinoma, cell line, testis .c 230 to 1039 1 to 814       814/874
(93 %)
9 diff
(99.0 %id)
BE142662 head_neck .c 242 to 449 205 to 1     Submitted on the opposite strand 205/205
(100 %)
5 diff
(97.6 %id)
AK022732   .c 247 to 2157 1 to 1909   available from FLJ,   1909/1909
(100 %)
5 diff
(99.8 %id)
AU125853   .c 248 to 1039 2 to 794   capped   793/811
(97 %)
8 diff
(99.1 %id)
BM453551 leiomyosarcoma, uterus .c 260 to 990 149 to 885       737/1133
(65 %)
19 diff
(98.4 %id)
AW748091 breast .c 261 to 819 562 to 3       560/562
(99 %)
17 diff
(97.0 %id)
CV027633 mixed .c 366 to 578 1 to 213       213/213
(100 %)
5 diff
(97.7 %id)
FN162128 breast carcinoma .c 388 to 476 1 to 89       89/89
(100 %)
0 diff
(100 %id)
BG386378 adenocarcinoma cell line, colon .c 399 to 1044 1 to 667       665/1005
(66 %)
45 diff
(95.6 %id)
BG387209 adenocarcinoma cell line, colon .c 399 to 1036 1 to 649       649/796
(81 %)
25 diff
(96.9 %id)
BE791730 lung, small cell carcinoma .c 451 to 1285 1 to 823       823/838
(98 %)
27 diff
(96.8 %id)
BF973410 leiomyosarcoma cell line, uterus .c 455 to 1208 1 to 754       754/977
(77 %)
21 diff
(97.9 %id)
BM051376 eye, normal pigmented retinal epithelium .c 519 to 1287 816 to 46     Submitted on the opposite strand 771/816
(94 %)
6 diff
(99.3 %id)
BQ070632 brain, neuroblastoma, cell line .c 550 to 1481 1 to 942       942/1013
(92 %)
13 diff
(98.8 %id)
BI255888 cervical carcinoma cell line, cervix .c 570 to 1457 1 to 891       889/897
(99 %)
21 diff
(97.7 %id)
BP225686   .c 599 to 1184 1 to 585       585/585
(100 %)
6 diff
(99.0 %id)
BQ675361 epidermoid carcinoma, cell line, salivary gland .c 603 to 1516 8 to 930       924/931
(99 %)
29 diff
(96.9 %id)
BG492623 lung, mucoepidermoid carcinoma .c 605 to 1244 2 to 653       652/897
(72 %)
18 diff
(98.0 %id)
BQ673068 epidermoid carcinoma, cell line, salivary gland .c 608 to 1477 1 to 881       881/881
(100 %)
10 diff
(98.9 %id)
BU174916 epidermoid carcinoma, cell line, salivary gland .c 608 to 1407 1 to 801       801/909
(88 %)
2 diff
(99.8 %id)
FN052159 breast carcinoma .c 617 to 713 1 to 97       97/97
(100 %)
1 diff
(99.0 %id)
BF170372 blood .c 628 to 935 1 to 303       303/305
(99 %)
17 diff
(94.5 %id)
BU933908 mixed (pool of 40 RNAs) .c 684 to 1474 1 to 795       795/795
(100 %)
11 diff
(98.7 %id)
BQ948059 epidermoid carcinoma, cell line, lung .c 742 to 1631 19 to 922       904/938
(96 %)
24 diff
(97.5 %id)
BM923451 pooled colon, kidney, stomach .c 841 to 1775 20 to 964       945/1095
(86 %)
27 diff
(97.6 %id)
FN171135 breast carcinoma .c 884 to 977 92 to 1     Submitted on the opposite strand 92/92
(100 %)
2 diff
(97.9 %id)
BE735042 choriocarcinoma, placenta .c 886 to 1797 11 to 911       901/1006
(89 %)
44 diff
(95.7 %id)
BG315272   .c 900 to 1061 162 to 1       162/162
(100 %)
1 diff
(99.4 %id)
BG678113 skin, squamous cell carcinoma .c 901 to 1816 1 to 908       908/908
(100 %)
19 diff
(98.0 %id)
BG480807 choriocarcinoma, placenta .c 903 to 1744 1 to 838       838/839
(99 %)
24 diff
(97.2 %id)
BE304537 adenocarcinoma cell line, colon .c 909 to 1565 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
BU849883 ovary, teratocarcinoma, cell line .c 948 to 1838 1 to 895       895/896
(99 %)
7 diff
(99.3 %id)
FN108179 breast carcinoma .c 1040 to 1121 1 to 82       82/82
(100 %)
4 diff
(95.2 %id)
BQ649561 hepatocellular carcinoma, cell line, Liver .c 1046 to 1688 13 to 666       654/949
(68 %)
35 diff
(96.4 %id)
BI086681 cervix .c 1049 to 1618 1 to 571       571/575
(99 %)
4 diff
(99.4 %id)
BQ424801 eye, retinoblastoma .c 1052 to 1935 1 to 885       885/886
(99 %)
13 diff
(98.6 %id)
BU540679 large cell carcinoma, lung .c 1056 to 1935 1 to 882       882/882
(100 %)
4 diff
(99.6 %id)
AI906971 breast .c 1093 to 1386 1 to 291       291/291
(100 %)
23 diff
(92.1 %id)
BI038625 nervous_tumor .c 1096 to 1671 598 to 25   tiling clone,   574/598
(95 %)
0 diff
(100 %id)
BE395847 endometrium, adenocarcinoma cell line, uterus .c 1183 to 1820 1 to 636       636/639
(99 %)
13 diff
(98.0 %id)
CK903461 Islets of Langerhans, Pancreas .c 1191 to 1809 1 to 619       619/619
(100 %)
3 diff
(99.6 %id)
BI793312 Islets of Langerhans, Pancreas .c 1207 to 1692 1 to 486   fully sequenced,   486/486
(100 %)
2 diff
(99.6 %id)
BI964856 Islets of Langerhans, Pancreas .c 1207 to 1700 1 to 494       494/494
(100 %)
2 diff
(99.6 %id)
BU175248 large cell carcinoma, lung .c 1207 to 2007 1 to 801       801/816
(98 %)
9 diff
(98.9 %id)
AL578648 placenta .c 1215 to 2152 934 to 1       934/939
(99 %)
8 diff
(99.2 %id)
AL560792 B cells from Burkitt lymphoma .c 1243 to 2166 1 to 924   tiling clone, fully sequenced,   924/924
(100 %)
1 diff
(99.9 %id)
AL560791 B cells from Burkitt lymphoma .c 1256 to 2134 879 to 1   fully sequenced,   879/879
(100 %)
2 diff
(99.8 %id)
BG332909 large cell carcinoma, lung .c 1300 to 1905 1 to 605       605/605
(100 %)
3 diff
(99.6 %id)
BM700778 eye, human retina .c 1320 to 1865 9 to 554       546/554
(98 %)
7 diff
(98.8 %id)
TI_149294827   .c 1323 to 2146 843 to 31   AAA   815/981
(83 %)
14 diff
(98.6 %id)
BX396458 Placenta Cot 25-normalized .c 1367 to 2155 1 to 825       741/830
(89 %)
28 diff
(96.7 %id)
CA425781 cell lines, Chondrosarcoma .c 1410 to 2165 774 to 19   AAA   756/756
(100 %)
0 diff
(100 %id)
BE765405 nervous_tumor .c 1522 to 1782 1 to 261       261/261
(100 %)
1 diff
(99.7 %id)
TI_149295837   .c 1543 to 2154 696 to 85   AAA   612/909
(67 %)
21 diff
(97.7 %id)
BG291875 bladder, transitional cell papilloma, cell line .c 1560 to 2149 1 to 589   AAA   589/589
(100 %)
1 diff
(99.9 %id)
DN914353   .c 1567 to 2134 567 to 1       567/567
(100 %)
1 diff
(99.9 %id)
CF129426 Chondrosarcoma Lung Metastasis cell lines, lung .c 1572 to 2146 1 to 573   AAA   573/573
(100 %)
1 diff
(99.9 %id)
TI_154191128   .c 1572 to 2146 51 to 623   AAA   573/573
(100 %)
1 diff
(99.9 %id)
BI771248 pooled lung and spleen .c 1573 to 2172 1 to 606       606/626
(96 %)
13 diff
(98.0 %id)
TI_57182693   .c 1573 to 2172 35 to 640       606/660
(91 %)
13 diff
(98.1 %id)
CK903460 Islets of Langerhans, Pancreas .c 1580 to 2159 578 to 1       578/578
(100 %)
8 diff
(98.7 %id)
AU149432   .c 1592 to 2157 568 to 1       568/568
(100 %)
14 diff
(97.6 %id)
BP383208 ilea mucosa .c 1597 to 2157 1 to 562       562/568
(98 %)
8 diff
(98.6 %id)
C02498   .c 1602 to 1922 1 to 320       320/320
(100 %)
8 diff
(97.5 %id)
AI742220 pooled .c 1640 to 2172 535 to 3       533/535
(99 %)
0 diff
(100 %id)
AI951445 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .c 1640 to 2154 515 to 1       515/515
(100 %)
0 diff
(100 %id)
AI983682 adenocarcinoma, Pancreas .c 1641 to 2160 520 to 1       520/520
(100 %)
0 diff
(100 %id)
BU683930 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1641 to 2154 527 to 15   AAA   513/513
(100 %)
8 diff
(98.5 %id)
BI963199 Islets of Langerhans, Pancreas .c 1653 to 2153 504 to 7       498/504
(98 %)
0 diff
(100 %id)
BI793010 Islets of Langerhans, Pancreas .c 1662 to 2159 495 to 1   fully sequenced,   495/495
(100 %)
6 diff
(98.8 %id)
DB571017 hypothalamus .c 1684 to 2153 1 to 467     Submitted on the opposite strand 467/468
(99 %)
4 diff
(99.2 %id)
AW519190 adenocarcinoma, Pancreas .c 1688 to 2175 488 to 1       488/488
(100 %)
0 diff
(100 %id)
BE208372.
matches multiple genes
adenocarcinoma cell line, ovary .c 1693 to 2160 470 to 2     also hits gene DOCK6 469/470
(99 %)
0 diff
(100 %id)
AW157386.
matches multiple genes
brain, frontal lobe .c 1698 to 2160 466 to 4     also hits gene RPL38 463/466
(99 %)
0 diff
(100 %id)
AW273040 colon, moderately-differentiated adenocarcinoma .c 1700 to 2155 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
DB523151 testis .c 1704 to 2161 1 to 456     Submitted on the opposite strand 456/456
(100 %)
1 diff
(99.8 %id)
AI079466 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1707 to 2151 445 to 1       445/445
(100 %)
0 diff
(100 %id)
DB574541 hypothalamus .c 1718 to 2168 1 to 449     Submitted on the opposite strand 449/449
(100 %)
1 diff
(99.8 %id)
DB556872 hypothalamus .c 1723 to 2168 1 to 442     Submitted on the opposite strand 442/442
(100 %)
6 diff
(98.7 %id)
CR617830 Neuroblastoma Cot 50-normalized .c 1724 to 2145 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BX334007 Neuroblastoma Cot 50-normalized .c 1727 to 2145 417 to 1       417/417
(100 %)
26 diff
(93.8 %id)
BX334008 Neuroblastoma Cot 50-normalized .c 1727 to 2160 1 to 432       432/432
(100 %)
4 diff
(99.1 %id)
AA622551 germ cell tumor .c 1730 to 2153 424 to 2       423/424
(99 %)
0 diff
(100 %id)
AI983014 adenocarcinoma, Pancreas .c 1730 to 2157 426 to 1       426/426
(100 %)
2 diff
(99.6 %id)
TI_154159481   .c 1733 to 2161 547 to 119   AAA Submitted on the opposite strand 429/433
(99 %)
0 diff
(100 %id)
BX104898 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1735 to 2157 437 to 15   AAA   423/423
(100 %)
0 diff
(100 %id)
AI934800 anaplastic oligodendroglioma, brain .c 1746 to 2180 443 to 11   AAA   433/433
(100 %)
1 diff
(99.8 %id)
EC502914 Prostate .c 1747 to 1856 1 to 107       107/107
(100 %)
2 diff
(98.2 %id)
BG473165 eye, retinoblastoma .c 1747 to 2165 1 to 419   AAA   419/419
(100 %)
4 diff
(99.1 %id)
AW503587 lymph .c 1753 to 2165 453 to 41   AAA Submitted on the opposite strand 413/413
(100 %)
2 diff
(99.6 %id)
EC459680 Prostate .c 1754 to 1856 23 to 124       102/127
(80 %)
3 diff
(97.7 %id)
AI561093 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1757 to 2159 403 to 1       403/403
(100 %)
4 diff
(99.1 %id)
DB513739 testis .c 1763 to 2147 1 to 384     Submitted on the opposite strand 384/386
(99 %)
8 diff
(98.0 %id)
BE254183 eye, retinoblastoma .c 1766 to 2163 1 to 396       396/396
(100 %)
1 diff
(99.8 %id)
AI554774 anaplastic oligodendroglioma, brain .c 1772 to 2180 407 to 1       407/407
(100 %)
1 diff
(99.8 %id)
AI375802 uterus .c 1800 to 2166 393 to 27   AAA   367/367
(100 %)
10 diff
(97.3 %id)
AA971352 pooled .c 1814 to 2149 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AI937243 anaplastic oligodendroglioma, brain .c 1821 to 2300 478 to 1       478/478
(100 %)
5 diff
(99.0 %id)
FN108570 breast carcinoma .c 1847 to 1915 67 to 1     Submitted on the opposite strand 67/68
(98 %)
1 diff
(98.6 %id)
AI886926 anaplastic oligodendroglioma, brain .c 1872 to 2180 304 to 1       304/311
(97 %)
16 diff
(94.9 %id)
BF447412 sympathetic trunk .c 1885 to 2171 287 to 1       287/287
(100 %)
3 diff
(99.0 %id)
AA564950 normal prostate, Prostate .c 1894 to 2175 282 to 1       282/282
(100 %)
0 diff
(100 %id)
BM672156 eye, human retina .c 1972 to 2368 415 to 19   tiling clone, AAA   397/397
(100 %)
0 diff
(100 %id)
AI472414 colon, moderately-differentiated adenocarcinoma .c 1996 to 2154 159 to 1       159/159
(100 %)
0 diff
(100 %id)
AA194730 muscle, skeletal muscle .c 2022 to 2176 155 to 1       155/157
(98 %)
0 diff
(100 %id)
AI553659 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2026 to 2160 135 to 1       135/135
(100 %)
0 diff
(100 %id)
EC557458 Prostate .c 2031 to 2153 129 to 3       127/129
(98 %)
0 diff
(100 %id)
FN052832 breast carcinoma .c 2039 to 2161 1 to 123       123/123
(100 %)
0 diff
(100 %id)
DA018846   .d 1 to 591 3 to 594   tiling clone, capped   593/593
(100 %)
3 diff
(99.5 %id)
DA664254   .d 1 to 243 3 to 245   capped   244/244
(100 %)
1 diff
(99.6 %id)
DA506888 brain .d 3 to 563 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
BQ946077 leiomyosarcoma, uterus .d 12 to 875 1 to 873   tiling clone,   873/884
(98 %)
21 diff
(97.7 %id)
BJ992066 hepatoblastoma .d 24 to 430 1 to 407       407/407
(100 %)
1 diff
(99.8 %id)
AW961185   .d 39 to 373 1 to 337       337/341
(98 %)
23 diff
(93.3 %id)
BE562869 endometrium, adenocarcinoma cell line, uterus .d 40 to 820 1 to 771   tiling clone,   771/793
(97 %)
23 diff
(97.1 %id)
AA313482 colon .d 43 to 501 5 to 463       464/466
(99 %)
12 diff
(97.5 %id)
BJ992067 hepatoblastoma .d 1822 to 2329 508 to 1   tiling clone,   508/508
(100 %)
0 diff
(100 %id)
BU194521 melanotic melanoma, skin .e 1 to 719 1 to 723   tiling clone,   723/840
(86 %)
11 diff
(98.7 %id)
BE336898 adenocarcinoma cell line, ovary .e 11 to 513 1 to 503       503/503
(100 %)
0 diff
(100 %id)
BE267078 lung, small cell carcinoma .e 671 to 1259 1 to 580   tiling clone,   580/897
(64 %)
26 diff
(97.2 %id)
CN427345 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 1030 to 1671 12 to 653   tiling clone,   642/653
(98 %)
7 diff
(99.0 %id)
CR616133 T cells (Jurkat cell line) Cot10-normalized .f 1 to 1339 1 to 1339 S24N tiling clone,   1339/1339
(100 %)
2 diff
(99.9 %id)
BE734617 choriocarcinoma, placenta .g 1 to 837 23 to 843 R2E R3G T7Q D8M G9V ... tiling clone,   823/1043
(78 %)
46 diff
(95.6 %id)
BE734555 choriocarcinoma, placenta .g 19 to 832 55 to 851   tiling clone,   799/887
(90 %)
38 diff
(95.8 %id)
BI115961 lung, small cell carcinoma .g 193 to 945 1 to 749       749/749
(100 %)
16 diff
(97.9 %id)
CR606255 B cells (Ramos cell line) Cot 25-normalized .g 348 to 1269 1 to 922   tiling clone,   922/922
(100 %)
0 diff
(100 %id)
EF688064   .h 1 to 2017 1 to 2017 exact tiling clone,   2017/2017
(100 %)
0 diff
(100 %id)
AW162069 brain, frontal lobe .h 1785 to 2154 1 to 369       369/369
(100 %)
1 diff
(99.8 %id)
AW163722 brain, frontal lobe .h 1785 to 2280 1 to 495   tiling clone,   495/495
(100 %)
1 diff
(99.8 %id)
AW754241 colon .h 2281 to 2804 129 to 652   tiling clone,   629/652
(96 %)
20 diff
(97.0 %id)
AL834467 melanoma (MeWo cell line) .h 2661 to 4173 1 to 1513   tiling clone, available from DKFZ, AAA   1513/1513
(100 %)
0 diff
(100 %id)
AL559524 T cells from T cell leukemia .h 2795 to 3591 1 to 796   fully sequenced,   796/796
(100 %)
2 diff
(99.8 %id)
BP398130 pancreatic islet .h 2873 to 3374 502 to 1       502/502
(100 %)
0 diff
(100 %id)
CX755234 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .h 2877 to 3395 1 to 519     Submitted on the opposite strand 519/763
(68 %)
42 diff
(94.5 %id)
BG760446 melanotic melanoma, high MDR (cell line), skin .h 2910 to 3741 1 to 831       831/831
(100 %)
7 diff
(99.2 %id)
BQ430587 embryonal carcinoma, cell line, testis .h 3249 to 4063 1 to 815       815/816
(99 %)
3 diff
(99.7 %id)
AL581123 T cells from T cell leukemia .h 3561 to 4135 573 to 1   fully sequenced,   573/573
(100 %)
5 diff
(99.2 %id)
AW156886 brain, frontal lobe .h 3632 to 4153 525 to 4       522/525
(99 %)
0 diff
(100 %id)
AW163198 brain, frontal lobe .h 3704 to 4153 453 to 4       450/453
(99 %)
0 diff
(100 %id)
CN427346 embryonic stem cells, cell lines H1, H7, andH9 .i 1 to 675 35 to 712 exact tiling clone,   678/712
(95 %)
13 diff
(98.2 %id)
BX415658 thymus .j-u 1 to 872 1 to 872 L3R H4V L5R A6P V7F ... tiling clone,   872/872
(100 %)
9 diff
(99.0 %id)
CR989260 T-Lymphocytes .j-u 735 to 1352 94 to 712   tiling clone,   619/712
(86 %)
6 diff
(99.2 %id)
BQ304086 breast .j-u 742 to 1141 405 to 5       401/405
(99 %)
0 diff
(100 %id)
AJ609443   .j-u 1279 to 1415 1 to 137   tiling clone,   137/137
(100 %)
0 diff
(100 %id)
NR_002968.1   .j-u 1279 to 1415 1 to 137   RefSeq,   137/137
(100 %)
0 diff
(100 %id)
AI879274 brain, frontal lobe .k 1 to 397 33 to 429   tiling clone,   399/429
(93 %)
11 diff
(97.5 %id)
DB105556 thymus .k 1 to 459 3 to 462 P18S V19S P20A R21Q V22G ... tiling clone, capped   461/461
(100 %)
4 diff
(99.2 %id)
AI928974 brain, frontal lobe .k 13 to 331 1 to 319       319/319
(100 %)
0 diff
(100 %id)
N89256   .k 26 to 277 1 to 252       252/255
(98 %)
10 diff
(96.1 %id)
BU902513 leiomyosarcoma, uterus .l 1 to 920 1 to 934 P76T tiling clone,   934/942
(99 %)
25 diff
(97.4 %id)
AA375840 lung .m 1 to 335 9 to 346 A4X Q5S L6S L7* tiling clone,   346/346
(100 %)
8 diff
(97.7 %id)
DA381952 thalamus .n 1 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
3 diff
(99.5 %id)
CB986269 Pooled-Glandular .n 887 to 1515 1 to 632 P28T tiling clone,   632/794
(79 %)
10 diff
(98.8 %id)
EH348578   .n 1096 to 1151 1 to 56       56/56
(100 %)
0 diff
(100 %id)
DB311465 thalamus .n 1511 to 2026 517 to 1   tiling clone,   517/517
(100 %)
2 diff
(99.7 %id)
DA936789 Spleen .o 1 to 514 2 to 515   tiling clone, capped   514/514
(100 %)
1 diff
(99.9 %id)
AA471083   .o 500 to 851 1 to 352   tiling clone,   352/352
(100 %)
4 diff
(98.9 %id)
DA042487 bladder .p 1 to 572 3 to 574   tiling clone, capped   573/573
(100 %)
2 diff
(99.7 %id)
DA747624   .p 1 to 565 3 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
DB193665 ovary, tumor tissue .p 1 to 568 3 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BI550871 brain, hippocampus .p 3 to 738 6 to 757       752/759
(99 %)
33 diff
(95.7 %id)
TI_44172206   .p 3 to 738 132 to 883       752/885
(84 %)
37 diff
(95.9 %id)
AK000443   .p 26 to 1906 1 to 1881 exact tiling clone, available from FLJ, AAA   1881/1881
(100 %)
3 diff
(99.9 %id)
DA258361 caudate nucleus .p 28 to 559 2 to 534   capped   533/533
(100 %)
4 diff
(99.3 %id)
BQ070726 brain, neuroblastoma, cell line .p 33 to 921 1 to 889   tiling clone,   889/1010
(88 %)
6 diff
(99.5 %id)
DN994257 brain, whole brain .p 49 to 651 12 to 614       605/614
(98 %)
6 diff
(99.1 %id)
BE778019 eye, retinoblastoma .p 85 to 825 1 to 742       742/1149
(64 %)
29 diff
(97.5 %id)
BP344238 synovial membrane .p 219 to 799 1 to 581       581/582
(99 %)
2 diff
(99.7 %id)
AA194163 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 1 to 462 1 to 458 exact tiling clone, fully sequenced,   458/458
(100 %)
0 diff
(100 %id)
AA194164 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 432 to 903 466 to 1   tiling clone, fully sequenced,   466/466
(100 %)
0 diff
(100 %id)
AA778949   .r-u -10 to 314 1 to 323   tiling clone,   323/323
(100 %)
7 diff
(97.9 %id)
BM040933 Kidney, Wilms' tumor, cell line .r-u 211 to 728 2 to 528   tiling clone,   527/528
(99 %)
6 diff
(98.9 %id)
BX098518 liver and spleen .s 1 to 726 1 to 726 exact tiling clone,   726/726
(100 %)
0 diff
(100 %id)
BQ322361 colon_est .t-u 1 to 516 14 to 525 C18G L42W tiling clone,   512/525
(97 %)
6 diff
(98.9 %id)
BQ322436 colon_est .t-u 8 to 505 20 to 514 exact tiling clone,   495/514
(96 %)
6 diff
(98.9 %id)
CV411910 colon_est .t-u 12 to 132 9 to 126       118/126
(93 %)
6 diff
(95.3 %id)
BQ322426 colon_est .t-u 50 to 604 560 to 3 exact tiling clone,   558/560
(99 %)
0 diff
(100 %id)
CV411914 colon_est .t-u 431 to 610 195 to 16   tiling clone, Submitted on the opposite strand 180/195
(92 %)
0 diff
(100 %id)
AJ609427   .t-u 468 to 604 1 to 137       137/137
(100 %)
0 diff
(100 %id)
NR_002951.1   .t-u 468 to 604 1 to 137   RefSeq,   137/137
(100 %)
0 diff
(100 %id)
BG012079 placenta_normal .u-u 1 to 493 499 to 1 V14G T15D E17G L18T L19F ... tiling clone,   499/499
(100 %)
18 diff
(96.4 %id)
DB457662 testis .va 1 to 468 1 to 468 exact tiling clone,   468/468
(100 %)
2 diff
(99.6 %id)
DW419950 Liver .va 15 to 256 9 to 250   tiling clone, AAA   242/250
(96 %)
6 diff
(97.6 %id)
DW417375 Liver .vb 1 to 293 13 to 305 F2G tiling clone,   293/306
(95 %)
8 diff
(97.4 %id)
DW423891 Liver .vb 1 to 278 13 to 290 F2G     278/290
(95 %)
9 diff
(96.9 %id)
AA999855 Kidney .vc-u 1 to 200 205 to 5 exact tiling clone,   201/205
(98 %)
0 diff
(100 %id)
AW754240 colon Gene CCNT1_, variant not shown         This clone was ignored    
CN270070 embryonic stem cells, DMSO-treated H9 cellline Gene CCNT1_, variant not shown              
DB310899 thalamus Gene CCNT1_, variant not shown              
DA371355 thalamus Gene CCNT1_, variant not shown       capped      
BU568231 testis Gene CCNT1_, variant not shown              
CF243150 Brain glioblastoma Gene CCNT1_, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o, .p, .q, .r-u, .s, .t-u, .u-u, .va, .vb, .vc-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI